Randomized phase II study of preoperative letrozole (Femara) in combination with avastin [bavacizumab] in hormone receptor positive breast cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer; Breast cancer
- Focus Therapeutic Use
- 16 Jun 2009 Novartis and Genentech added as trial sponsor as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned end date changed from 1 Dec 2009 to 1 May 2010 as reported by ClinicalTrials.gov.
- 08 May 2007 New trial record.